1. 2005
2. Published

   Drugs for exceptionally rare diseases: do they deserve special status for funding?

   Hughes, D., Tunnage, B. & Yeo, S. T., 1 Nov 2005, In: QJM - An International Journal of Medicine. 98, 11, p. 829-836

   Research output: Contribution to journal › Article › peer-review

3. Published

   Incorporating measures of compliance and persistence in pharmacoeconomic evaluations

   Hughes, D., Hughes, D. A. & Cowell, W., 1 Nov 2005.

   Research output: Contribution to conference › Paper

4. Published

   Public funding of drugs for orphan diseases

   Hughes, D. & Hughes, D. A., 1 Nov 2005.

   Research output: Contribution to conference › Paper

5. Published

   Public funding of drugs for orphan diseases

   Hughes, D. & Hughes, D. A., 1 Nov 2005.

   Research output: Contribution to conference › Paper

6. Published

   Trends and influences on use of antidiabetic drugs in England, 1992-2003.

   Walley, T., Hughes, D. & Kendall, H., 1 Nov 2005, In: Pharmacoepidemiology and Drug Safety. 14, 11, p. 769-773

   Research output: Contribution to journal › Article › peer-review

7. Published

   Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.

   Hughes, D. & Hughes, D. A., 1 Jul 2005, In: European Journal of Cancer. 41, 11, p. 1655

   Research output: Contribution to journal › Article › peer-review

8. Published

   Public funding of drugs for orphan diseases

   Hughes, D. & Hughes, D. A., 1 Jul 2005.

   Research output: Contribution to conference › Paper

9. Published

   Empirical analysis of the relationship between dose and duration of drug action

   Hughes, D. & Hughes, D. A., 1 Jun 2005.

   Research output: Contribution to conference › Paper

10. Published

    Pharmacokinetics, patient compliance and pharmaeconomics

    Hughes, D. & Hughes, D. A., 1 Jun 2005.

    Research output: Contribution to conference › Paper

11. Published

    Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

    Hughes, D., Hughes, D. A., Marchetti, M. & Colombo, G., 1 Feb 2005, In: Expert Review of Pharmacoeconomics and Outcomes Research. 5, 1, p. 29-38

    Research output: Contribution to journal › Article › peer-review